Average Co-Inventor Count = 7.47
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (35 from 4,942 patents)
2. Siena Biotech S.p.a. (3 from 11 patents)
3. Bright Peak Therapeutics Ag (1 from 3 patents)
4. Black Diamond Therapeutics, Inc. (1 from 2 patents)
5. F. Hoffmann-la Roche Ag (168 patents)
37 patents:
1. 11633488 - Modified IL-2 polypeptides and uses thereof
2. 11034672 - Tyrosine kinase inhibitor compositions, methods of making and methods of use
3. 10035804 - Spirodiamine derivatives as aldosterone synthase inhibitors
4. 9796702 - Dihydroquinoline pyrazolyl compounds
5. 9796726 - Dihydroquinoline pyrazolyl compounds
6. 9790200 - Dihydroquinoline pyrazolyl compounds
7. 9790217 - Pyridinyloxy- and phenyloxy-pyrazolyl compounds
8. 9695151 - 3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds
9. 9695152 - 3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds
10. 9636339 - Phenyl-dihydropyridine derivatives as aldosterone synthase inhibitors
11. 9636338 - Phenyl-dihydropyridine derivatives as inhibitors of aldosterone synthase
12. 9593107 - Dihydroquinoline-2-one derivatives
13. 9505742 - 3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds
14. 9464058 - Imidazolylketone derivatives
15. 9458135 - Dihydroquinoline-2-one derivatives